ANIK FY 2025 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$113M-5.9% YoY

Gross Profit

$64M56.6% margin

Operating Income

-$11M-9.8% margin

Net Income

-$11M-9.6% margin

EPS (Diluted)

$-0.76

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$4M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$190M

Total Liabilities

$47M

Stockholders' Equity

$143M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$113M	$120M	-5.9%
Gross Profit	$64M	$76M	-16.0%
Operating Income	-$11M	-$5M	-116.6%
Net Income	-$11M	-$56M	+80.7%